Skip to main content
Veterinary Medicines

KESIUM 500 MG / 125 MG CHEWABLE TABLETS FOR DOGS

Authorised
  • Amoxicillin trihydrate
  • Potassium clavulanate

Product identification

Medicine name:
KESIUM 500 MG / 125 MG CHEWABLE TABLETS FOR DOGS
Kesium 500 mg / 125 mg Kautabletten für Hunde
Active substance:
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    574.00
    milligram(s)
    /
    1.00
    Tablet
  • Potassium clavulanate
    149.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Box of 80 blisters (PA-AL-PVC – aluminium heat sealed) of 6 tablets
  • Box of 80 blisters (PA-AL-PVC – aluminium heat sealed) of 6 tablets
  • Box of 80 blisters (PA-AL-PVC – aluminium heat sealed) of 6 tablets
  • Box of 80 blisters (PA-AL-PVC – aluminium heat sealed) of 6 tablets
  • Box of 80 blisters (PA-AL-PVC – aluminium heat sealed) of 6 tablets
  • Box of 80 blisters (PA-AL-PVC – aluminium heat sealed) of 6 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Tiergesundheit GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401827.00.00
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0225/005
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 2/07/2025